Topical Antibiotics Market Size Projected to Reach USD 10.0 billion by 2031, With 5.1% CAGR: Transparency Market Research, Inc.
21 févr. 2024 00h40 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global topical antibiotics market is estimated to flourish at a CAGR of 5.1% from 2023...
Wound Irrigation Systems Market to Grow at a CAGR of 4.4% from 2022 to 2031, reaching US$ 419.1 Million: As per TMR Study
10 juil. 2023 04h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, July 10, 2023 (GLOBE NEWSWIRE) -- The global wound irrigation systems market stood at US$ 269.8 million in 2021, and the global market is projected to reach US$...
Antibiotics Global Market Report 2023: Significant Growth Potential of Cell Wall and Protein Inhibitor Drugs Bodes Well for Sector
23 mai 2023 04h18 HE
|
Research and Markets
Dublin, May 23, 2023 (GLOBE NEWSWIRE) -- The "Antibiotics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for antibiotics was...
Topical Antibiotics Market to Witness Substantial Growth of USD 10.68 Billion with Healthy CAGR of 6.3% by 2029, Size, Share, Trends, Growth, Major Developments and Competitors Insight
24 janv. 2023 21h30 HE
|
Data Bridge Market Research
Philadelphia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- "Topical Antibiotics Market" is the title of a new report from Data Bridge Market Research. Key growth strategies, drivers, opportunities, key...
Biofrontera Inc. Reports Third Quarter 2022 Financial Results and Provides a Business Update
14 nov. 2022 08h45 HE
|
Biofrontera Inc.
Conference call begins at 11:00 a.m. Eastern time today WOBURN, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the...
Biofrontera Inc. to Report Third Quarter Financial Results on November 14, 2022
10 nov. 2022 11h52 HE
|
Biofrontera Inc.
WOBURN, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announces it will...
Biofrontera Inc. Announces Pricing of $9.4 Million Private Placement
16 mai 2022 08h00 HE
|
Biofrontera Inc.
WOBURN, MA., May 16, 2022 (GLOBE NEWSWIRE) -- Biofrontera, Inc. (Nasdaq: BFRI; BFRIW), announced today that it has entered into a securities purchase agreement with a single institutional investor...
Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022
06 mai 2022 08h25 HE
|
Biofrontera Inc.
WOBURN, Mass., May 06, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, will report financial...
At a CAGR of 6.1%, Global Burn Ointment Market to Surpass US$ 1,384.4 Million by 2028, Says Coherent Market Insights (CMI)
14 juil. 2021 08h40 HE
|
CMI
SEATTLE, July 14, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global burn ointment market is estimated to be valued at US$ 915.7 million in 2021 and is expected to exhibit a...
Antibiotics Technologies and Markets, 2025
12 janv. 2021 04h38 HE
|
Research and Markets
Dublin, Jan. 12, 2021 (GLOBE NEWSWIRE) -- The "Antibiotics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for antibiotics should...